JILL JACOSKI: Open Payments
NPI 1841549102 · OCEAN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 15 payments from 8 companies in 2025. Trend: 2023 $193 · 2024 $440 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 2 | $297 |
| Kestra Medical Technology Services, Inc. | 7 | $164 |
| Novo Nordisk Inc | 1 | $110 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $99 |
| AstraZeneca Pharmaceuticals LP | 1 | $56 |
| Hologic Sales and Service, LLC | 1 | $22 |
| Abbott Laboratories | 1 | $17 |
| HEARTFLOW, INC. | 1 | $16 |
Products named: AMVUTTRA, Assure WCD, Ozempic, LifeVest, WAINUA, MYOSURE TISSUE REMOVAL DEVICE, MERLIN@HOME, FFRct.
Industry payments across NJ — which companies pay providers there.
